101. Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway.
- Author
-
Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, and Jenum AK
- Subjects
- Adult, Antihypertensive Agents therapeutic use, Asia ethnology, Chi-Square Distribution, Cross-Sectional Studies, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 therapy, Electronic Health Records, Female, Glycated Hemoglobin analysis, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Linear Models, Male, Middle Aged, Norway, Obesity complications, Obesity ethnology, Process Assessment, Health Care, Diabetes Mellitus, Type 2 ethnology, Family Practice standards, Hypoglycemic Agents therapeutic use, Minority Groups statistics & numerical data, Quality of Health Care
- Abstract
Background: In recent decades immigration to Norway from Asia, Africa and Eastern Europe has increased rapidly. The aim of this study was to assess the quality of care for type 2 diabetes mellitus (T2DM) patients from these ethnic minority groups compared with the care received by Norwegians., Methods: In 2006, electronic medical record data were screened at 11 practices (49 GPs; 58857 patients). 1653 T2DM patients cared for in general practice were identified. Ethnicity was defined as self-reported country of birth. Chi-squared tests, one-way ANOVAs, multiple regression, linear mixed effect models and generalized linear mixed models were used., Results: Diabetes was diagnosed at a younger age in patients from the ethnic minority groups (South Asians (SA): mean age 44.9 years, Middle East/North Africa (MENA): 47.2 years, East Asians (EA): 52.0 years, others: 49.0 years) compared with Norwegians (59.7 years, p < 0.001). HbA1c, systolic blood pressure (SBP) and s-cholesterol were measured in >85% of patients in all groups with minor differences between minority groups and Norwegians. A greater proportion of the minority groups were prescribed hypoglycaemic medications compared with Norwegians (>or=79% vs. 72%, p < 0.001). After adjusting for age, gender, diabetes duration, practice and physician unit, HbA1c (geometric mean) for Norwegians was 6.9% compared to 7.3-7.5% in the minority groups (p < 0.05). The proportion with poor glycaemic control (HbA1c > 9%) was higher in minority groups (SA: 19.6%, MENA: 18.9% vs. Norwegians: 5.6%, p < 0.001. No significant ethnic differences were found in the proportions reaching the combined target: HbA1c
- Published
- 2010
- Full Text
- View/download PDF